颅内动脉狭窄血管内治疗概论 颅内动脉狭窄的流行病学 颅内动脉狭窄的病因颅内动脉狭窄的病理生理 颅内动脉狭窄的临床表现 颅内动脉狭窄的治疗选择
返回首页

颅内动脉硬化性狭窄病理生理

时间:2016-06-04 15:01来源:未知 作者:Mr.Editor
颅内动脉硬性狭窄是一个严重的疾
颅内动脉硬性狭窄是一个严重的疾病。Intracranial atherosclerosis is a very serious disease:
 
1. 颅内动脉狭窄50-99%发生同侧中风:尽管进行内科治疗第1年内发生中风的几率11%。Stroke ipsilat to ic stenosis (50-99%): 11% within 1st yr despite medical tx
 
2.  WASID 临床试验(trial): 【1~3】
(1)70-99%颅内动脉狭窄的患者,尽管充分的内科治疗(抗血栓治疗+血管危险因素的处理)
         pts w 70-99% intracranial stenosis are at particularly high risk for stroke despite full medical tx ( antithrombotic+management of vascular risk factors),
(2)70%以上狭窄,在第一年发生中风的危险22%, 病情恶化或由于华法令导致颅内出血。
         70%+ stenosis: 22% risk at first yr w medical tx (ASA) worse due to incrd risk of hemorrhage w warfarin.

3.  内科治疗失败并不增加风险
     Medical failures do not add on the risk ,therefore being one time symptomatic is good enough for high risk
 
4.  再通的选择是PTA和/或 支撑架
     Revascularization choice is PTA and/or Stenting


1. Khan A, Kasner SE, Lynn MJ, Chimowitz MI; Warfarin Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators. Risk factors and outcome of patients with symptomatic intracranial stenosis presenting with lacunar stroke. Stroke. 2012 May;43(5):1230-3.
 
2. Famakin BM, Chimowitz MI, Lynn MJ, Stern BJ, George MG; WASID Trial Investigators. Causes and severity of ischemic stroke in patients with symptomatic intracranial arterial stenosis.Stroke. 2009 Jun;40(6):1999-2003. 
 
3. Turan TN, Cotsonis G, Lynn MJ, Chaturvedi S, Chimowitz M; Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators.Relationship between blood pressure and stroke recurrence in patients with intracranial arterial stenosis. Circulation. 2007 Jun 12;115(23):2969-75. 

顶一下
(0)
0%
踩一下
(0)
0%
------分隔线----------------------------
  • 上一篇:没有了
  • 下一篇:没有了
推荐内容